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Now the College is
announcing that the
ACC Surgeons’
Council will
establish a
corresponding
Surgeons’ Section
open to all ACC
members.Where would we be without each other? Those of us who have been practicing for more than
35 years remember when we catheterizers and the cardiothoracic surgeons were viewed by some of
our less invasively inclined colleagues as “cognitively challenged cowboys.” Under much scrutiny,
we defended each other as a family. Neither could exist without the other. A brief reﬂection on the
history of myocardial revascularization will show that surgical techniques, from epicardial abrasion,
to the Vineberg procedure, to the patch grafting introduced by Ake Senning, to vein bypass surgery
as a bailout by DeBakey and Garrett, all gave way to more rational approaches only after the
development of selective coronary arteriography by Mason Sones and all who followed. Favaloro
could not have succeeded without Sones, nor Sones without Favaloro. Although myocardial
revascularization has dominated both specialties, the necessary collaboration in advancing the
therapy of structural heart disease has been equally important.
The birth of interventional cardiology by Andreas Gruentzig was made possible by the successes
and failures of surgical approaches. Ake Senning, the surgeon, was an important enabler of
Gruentzig as he faced understandable skepticism from some of his colleagues. As in any family,
rivalries can develop, and the cardiovascular medicine family is no exception. Angioplasty and
stenting naturally became competitors with surgery, and they remain so. This is not a bad thing,
and the relative merits as applied to speciﬁc situations and patients have been one of the most
important contributions our specialty has made to cardiovascular research. However, an unnec-
essary and damaging side effect of such competition has been the estrangement of the practitioners
of the surgical and interventional methods. Although surgeons rarely work in isolation from
invasive cardiologists, technical advances have enabled interventional cardiologic procedures with
minimal surgical input.
After a number of years of drifting apart, cardiovascular surgeons and adult cardiologists are
ﬁnding the value of collaboration again. Acquired structural heart disease has been the catalyst, and
TAVI (TAVR?) is a poster child for working together to bring the best skills and knowledge to
address the problem of aortic stenosis. As less invasive approaches to mitral valve disease are
developed, that joint effort will be even more important for a more complex structure. The value of
collaboration has also been demonstrated in myocardial revascularization in more complex
anatomical and clinical presentations. The SYNTAX (Synergy Between Percutaneous Coronary
Intervention With Taxus and Cardiac Surgery) trial was pivotal in convincing many that surgical
and cardiology consultation is worthwhile. Likewise, the realization that the selection of therapy
beneﬁts from input from clinical cardiology, invasive cardiology, cardiac surgery, and the patient has
led to the Class I recommendation for use of the “heart team approach” by both the American
College of Cardiology (ACC) and American Heart Association guidelines and the European
Society of Cardiology guidelines. The value of cooperation between surgery and cardiology in
treatment selection, technical performance, and translational research to advanced care is increas-
ingly realized. In response to this need, the ACC has taken an important step to further engage our
surgeon colleagues in the activities of the College. Over the past several years, the ACC has
established a number of member sections that are designed to serve the interests of various member
constituencies. They are charged with coordinating activities across the College’s mission “pillars”
of: 1) science and quality; 2) advocacy; and 3) lifelong learning. Now the College is announcing that
the ACC Surgeons’ Council will establish a corresponding Surgeons’ Section open to all ACC
members. It is expected that the Surgeons’ Section will offer involvement for all ACC members
interested in working at the chapter, committee, section, and national levels to build sustaining
activities focused on enhancing surgical and cardiology collaboration and fostering the heart team
approach. The work of the Surgeons’ Section will build on the successes the College has had in
developing partnerships with leading national surgeon societies. The Surgeons’ Section will serve as
a coordinating central locus for members interested in introducing activities that will promote
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1109collaboration between surgeons and cardiologists. The
Surgeons’ Section expects to interact with several
current member sections, as well as to maintain strong
relations with surgical societies, such as the Society of
Thoracic Surgeons and the American Association for
Thoracic Surgery. Current Surgeon Council leadership
essential to establishing the Surgeons’ Section includes
James McClurken, MD, FACC, Vinod Thourani,
MD, FACC, Fred Grover, MD, FACC, and Hani
Najm, MD, FACC, to recognize a few of the leaders.
As we are pressed more and more to deﬁne patients
who are appropriate for our therapies, we must realize
that medicine is more than ﬁnding the right box in
which to put our patients. The heart team approach
applied to individual patients brings true personalized
medicine. The collaboration across clinical cardiology,
invasive cardiology, and cardiac surgery is also neces-
sary to help reﬁne the deﬁnitions of appropriate use,
which will remain an inescapable part of practice.
Hopefully, this section will provide a forum forinﬂuencing rational policy decisions about such
criteria.
How do you get involved? All ACC members and
others interested in contributing to this initiative can
join the Surgeons’ Section by contacting Stephanie
Mitchell at smitchel@acc.org. College and Surgeon
Council leadership is hopeful that surgeons who
are not yet members of the ACC will ﬁnd this an
interesting opportunity to connect more closely with
their cardiology colleagues at the local and national
levels and also to inﬂuence the future of the ACC and
advance the care of the cardiovascular patient.Address correspondence to:
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